Alexander C. S. N. Jeanrenaud
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Alexander C. S. N. Jeanrenaud has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Ahla Ghauri
Max Delbrück Center for Molecular Medicine Helmholtz Association Berlin Germany
4 shared publications - Aleix Arnau-Soler
Max Delbrück Center for Molecular Medicine Helmholtz Association Berlin Germany
4 shared publications - Kirsten Beyer
Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité—Universitätsmedizin Berlin, 13353 Berlin, Germany
4 shared publications - Ingo Marenholz
Max Delbrück Center for Molecular Medicine Helmholtz Association Berlin Germany
3 shared publications - Margitta Worm
Division of Allergy and Immunology, Department of Dermatology, Venereology and Allergy Charité—University Medical Center Berlin, Corporate Member of Freie Universität Berlin and Humboldt‐Universität Zu Berlin Berlin Germany
3 shared publications - Young-Ae Lee
Max Delbrück Center for Molecular Medicine Helmholtz Association Berlin Germany
3 shared publications
Latest Publications
- Open Access
Multi‐Omics Analysis Reveals Vitamin D Metabolism, Hyper‐ IgE Genes, and Epithelial Barrier Dysfunction in Hazelnut Allergy
Background: Hazelnut allergy is a major cause of food‐induced anaphylaxis yet remains poorly defined at the molecular level. We aimed to identify molecular differences between individuals with primary hazelnut allergy and nonallergic controls by investigating a comprehensive spectrum of omics profiles in immune cells. Methods: We analysed DNA methylation, transcriptomic, and proteomic profiles in hazelnut‐stimulated and unstimulated immune cells. Results: Across analyses, we identified 87 differentially methylated signatures, 125 unique differentially expressed genes, and 11 unique differentially secreted proteins associated with hazelnut allergy. DNA methylation signatures were largely preserved irrespective of antigen stimulation, indicating stable epigenetic remodelling. Key findings implicated ZNF341 , associated with a rare monogenic hyper‐IgE syndrome, and ARL2 , both linked to STAT3‐mediated IgE dysregulation. We identified a hypermethylated region overlapping TH2LCRR in the cytokine gene cluster, suggesting an epigenetic mechanism contributing to IL‐5 and IL‐13 upregulation. Antigen stimulation was required to reveal hazelnut‐specific transcriptional and proteomic signals. Integration of these data demonstrated that IL‐5 expression could distinguish both groups. Moreover, integrated analysis of all multi‐omics data revealed prominent innate immune activation programs involving antimicrobial, antiviral, and cytokine‐mediated inflammatory responses. Finally, we identified signals in epithelial barrier genes of the gut and skin ( TRIM31 , TRIM40 , CDSN ), activation of the vitamin D pathway ( CYP27B1 , IL32 ), and nominated additional signals ( PHACTR1, MFHAS1, SPRED2, NSMCE1‐DT ) for follow‐up. Conclusion: This study provides the first antigen‐specific multi‐omics characterization of hazelnut allergy, confirming coordinated alterations in type 2‐immunity and uncovering novel links to monogenic hyper‐IgE syndrome, innate inflammatory pathways, activation of vitamin‐D pathways, and gut/skin barrier genes, yielding a catalogue of candidate biomarkers for mechanistic studies and prospective validation.
Open AccessMulti‐Omics Analysis Reveals Vitamin D Metabolism, Hyper‐ IgE Genes, and Epithelial Barrier Dysfunction in Hazelnut Allergy
Background: Hazelnut allergy is a major cause of food‐induced anaphylaxis yet remains poorly defined at the molecular level. We aimed to identify molecular differences between individuals with primary hazelnut allergy and nonallergic controls by investigating a comprehensive spectrum of omics profiles in immune cells. Methods: We analysed DNA methylation, transcriptomic, and proteomic profiles in hazelnut‐stimulated and unstimulated immune cells. Results: Across analyses, we identified 87 differentially methylated signatures, 125 unique differentially expressed genes, and 11 unique differentially secreted proteins associated with hazelnut allergy. DNA methylation signatures were largely preserved irrespective of antigen stimulation, indicating stable epigenetic remodelling. Key findings implicated ZNF341 , associated with a rare monogenic hyper‐IgE syndrome, and ARL2 , both linked to STAT3‐mediated IgE dysregulation. We identified a hypermethylated region overlapping TH2LCRR in the cytokine gene cluster, suggesting an epigenetic mechanism contributing to IL‐5 and IL‐13 upregulation. Antigen stimulation was required to reveal hazelnut‐specific transcriptional and proteomic signals. Integration of these data demonstrated that IL‐5 expression could distinguish both groups. Moreover, integrated analysis of all multi‐omics data revealed prominent innate immune activation programs involving antimicrobial, antiviral, and cytokine‐mediated inflammatory responses. Finally, we identified signals in epithelial barrier genes of the gut and skin ( TRIM31 , TRIM40 , CDSN ), activation of the vitamin D pathway ( CYP27B1 , IL32 ), and nominated additional signals ( PHACTR1, MFHAS1, SPRED2, NSMCE1‐DT ) for follow‐up. Conclusion: This study provides the first antigen‐specific multi‐omics characterization of hazelnut allergy, confirming coordinated alterations in type 2‐immunity and uncovering novel links to monogenic hyper‐IgE syndrome, innate inflammatory pathways, activation of vitamin‐D pathways, and gut/skin barrier genes, yielding a catalogue of candidate biomarkers for mechanistic studies and prospective validation.
- Open Access
Multi-omics analysis reveals vitamin D metabolism, hyper-IgE genes, and epithelial barrier dysfunction in hazelnut allergy
Background: Hazelnut allergy is a major cause of food-induced anaphylaxis yet remains poorly defined at the molecular level. Objective: We aimed to identify molecular differences between individuals with primary hazelnut allergy and nonallergic controls by investigating a comprehensive spectrum of omics profiles in immune cells. Methods: We analysed DNA methylation, transcriptomic and proteomic profiles in hazelnut-stimulated and unstimulated immune cells. Results: Across analyses, we identified 80 differentially methylated signatures, 125 differentially expressed genes, and 11 differentially secreted proteins associated with hazelnut allergy. DNA methylation signatures were highly concordant between unstimulated and stimulated conditions, consistent with stable epigenetic remodelling. Key findings implicated ZNF341, associated with a rare monogenic hyper-IgE syndrome, and ARL2, both linked to STAT3-mediated IgE dysregulation. Additionally, we identified a differentially methylated region (DMR) overlapping the T Helper Type 2 Locus Control Region Associated RNA (TH2LCRR) in the cytokine gene cluster, suggesting an epigenetic mechanism contributing to IL-5 and IL-13 upregulation. Antigen stimulation was required to reveal hazelnut-specific transcriptional and proteomic signals. Integration of these data demonstrated that IL-5 expression could distinguish both groups. We identified signals in epithelial barrier genes of the gut and skin (TRIM31, TRIM40, CDSN), activation of the vitamin D pathway (CYP27B1, IL32), and nominate additional signals (PHACTR1, MFHAS1, SPRED2, GALNT5/GALNTL4, NSMCE1-DT) for follow-up. Conclusion: Our study confirms type-2 cytokines, FcEpsilonRI, and JAK-STAT signalling and uncovers novel links to monogenic hyper-IgE syndrome, activation of vitamin-D pathways, and gut/skin barrier genes, yielding a catalogue of candidate biomarkers for mechanistic studies and prospective validation.
Open AccessMulti-omics analysis reveals vitamin D metabolism, hyper-IgE genes, and epithelial barrier dysfunction in hazelnut allergy
Background: Hazelnut allergy is a major cause of food-induced anaphylaxis yet remains poorly defined at the molecular level. Objective: We aimed to identify molecular differences between individuals with primary hazelnut allergy and nonallergic controls by investigating a comprehensive spectrum of omics profiles in immune cells. Methods: We analysed DNA methylation, transcriptomic and proteomic profiles in hazelnut-stimulated and unstimulated immune cells. Results: Across analyses, we identified 80 differentially methylated signatures, 125 differentially expressed genes, and 11 differentially secreted proteins associated with hazelnut allergy. DNA methylation signatures were highly concordant between unstimulated and stimulated conditions, consistent with stable epigenetic remodelling. Key findings implicated ZNF341, associated with a rare monogenic hyper-IgE syndrome, and ARL2, both linked to STAT3-mediated IgE dysregulation. Additionally, we identified a differentially methylated region (DMR) overlapping the T Helper Type 2 Locus Control Region Associated RNA (TH2LCRR) in the cytokine gene cluster, suggesting an epigenetic mechanism contributing to IL-5 and IL-13 upregulation. Antigen stimulation was required to reveal hazelnut-specific transcriptional and proteomic signals. Integration of these data demonstrated that IL-5 expression could distinguish both groups. We identified signals in epithelial barrier genes of the gut and skin (TRIM31, TRIM40, CDSN), activation of the vitamin D pathway (CYP27B1, IL32), and nominate additional signals (PHACTR1, MFHAS1, SPRED2, GALNT5/GALNTL4, NSMCE1-DT) for follow-up. Conclusion: Our study confirms type-2 cytokines, FcEpsilonRI, and JAK-STAT signalling and uncovers novel links to monogenic hyper-IgE syndrome, activation of vitamin-D pathways, and gut/skin barrier genes, yielding a catalogue of candidate biomarkers for mechanistic studies and prospective validation.
- Open Access
Understanding the Variability of Peanut‐Oral Immunotherapy Responses by Multi‐Omics Profiling of Immune Cells
Background: Oral immunotherapy (OIT) induces desensitization in peanut allergy, yet 15%–30% of patients do not respond, and a significant risk of anaphylaxis due to treatment remains. In a placebo‐controlled peanut OIT trial, this study identifies molecular drivers of OIT responsiveness through multi‐omics profiling in immune cells. Methods: Immunoglobulins, cytokines, transcriptome, and DNA methylome profiles were analyzed in peanut‐stimulated and unstimulated peripheral blood mononuclear cells isolated from peanut‐allergic children before and after treatment. Multi‐omics profiling focused on OIT responsiveness within the active treatment arm. Additional subgroup analyses were performed to further elucidate molecular mechanisms and potential biomarkers. Results: Complete responders, tolerating 4500 mg of peanut protein, exhibited lower pre‐treatment peanut‐specific IgE and Th2 cytokine production (IL‐4, IL‐5) compared to incomplete responders who tolerated ≤ 1000 mg of peanut protein after treatment. Our primary analysis identified 184 differentially expressed genes and 1001 differentially methylated genes, enriched for innate (ILC3) and adaptive (CD8αα subset of CD8 + T cells) immune cells, alongside γδ T cells and exosomes, highlighting gastrointestinal regulatory processes as central to OIT success. We found a marked downregulation of immunoglobulin genes in patients receiving peanut compared to placebo, suggesting OIT‐induced modulation of B‐cell activity. Functional networks revealed a marked imbalance contrasting regulatory T‐cell responses and B‐cell suppression in the complete responders with innate immune signaling and metabolic stress in the incomplete responders. Conclusion: This multi‐omics approach underscores the importance of gastrointestinal immune mechanisms underlying the variation in peanut oral immunotherapy responses and offers potential biomarkers for improving treatment strategies. Trial Registration: German Clinical Trials Register DRKS00004553
Open AccessUnderstanding the Variability of Peanut‐Oral Immunotherapy Responses by Multi‐Omics Profiling of Immune Cells
Background: Oral immunotherapy (OIT) induces desensitization in peanut allergy, yet 15%–30% of patients do not respond, and a significant risk of anaphylaxis due to treatment remains. In a placebo‐controlled peanut OIT trial, this study identifies molecular drivers of OIT responsiveness through multi‐omics profiling in immune cells. Methods: Immunoglobulins, cytokines, transcriptome, and DNA methylome profiles were analyzed in peanut‐stimulated and unstimulated peripheral blood mononuclear cells isolated from peanut‐allergic children before and after treatment. Multi‐omics profiling focused on OIT responsiveness within the active treatment arm. Additional subgroup analyses were performed to further elucidate molecular mechanisms and potential biomarkers. Results: Complete responders, tolerating 4500 mg of peanut protein, exhibited lower pre‐treatment peanut‐specific IgE and Th2 cytokine production (IL‐4, IL‐5) compared to incomplete responders who tolerated ≤ 1000 mg of peanut protein after treatment. Our primary analysis identified 184 differentially expressed genes and 1001 differentially methylated genes, enriched for innate (ILC3) and adaptive (CD8αα subset of CD8 + T cells) immune cells, alongside γδ T cells and exosomes, highlighting gastrointestinal regulatory processes as central to OIT success. We found a marked downregulation of immunoglobulin genes in patients receiving peanut compared to placebo, suggesting OIT‐induced modulation of B‐cell activity. Functional networks revealed a marked imbalance contrasting regulatory T‐cell responses and B‐cell suppression in the complete responders with innate immune signaling and metabolic stress in the incomplete responders. Conclusion: This multi‐omics approach underscores the importance of gastrointestinal immune mechanisms underlying the variation in peanut oral immunotherapy responses and offers potential biomarkers for improving treatment strategies. Trial Registration: German Clinical Trials Register DRKS00004553
- Open Access
- 10 May 2023
- Published by Academy of Science of South Africa in African Entomology
- Vol. 31
The effect of pollution on the competitive dynamics of Anopheles arabiensis Patton, 1905 and Culex quinquefasciatus Say, 1823 (Diptera: Culicidae)
Culex quinquefasciatus Say, 1823 and Anopheles arabiensis Patton, 1905 (Diptera: Culicidae) are often found breeding in the same water sources and engage in interspecific competition. Although Cx. quinquefasciatus is known to proliferate in a range of polluted environments, the ability of An. arabiensis to proliferate in polluted water has only been reported relatively recently. The effects of pollution and insecticide resistance on this competitive interaction are unknown. This study examined the effect of pollution on the dynamics of the interspecific competition. Three laboratory strains were used in this study: an insecticide susceptible and an insecticide resistant An. arabiensis, and an insecticide resistant Cx. quinquefasciatus. Larval pollutant tolerances of each strain were assessed and compared by determining the lethal concentration at 50% mortality (LC50). The larvae from each strain were exposed to either inorganic fertiliser or copper nitrate, following which eclosion success was assessed. The results showed that the insecticide resistant strains had higher emergence rates when reared in polluted conditions without competition, with the Cx. quinquefasciatus strain showing the highest rate of eclosion. This species also had a higher tolerance for metal pollution than the An. arabiensis strains. The effects of pollutants on oviposition choice were examined. Pollution altered adult oviposition choice. The effect of larval metal exposure had variable effects on the activity of metabolic detoxification enzymes. An insecticide resistant phenotype had greater tolerance to pollutants and possibly developmental advantages based on a variable detoxification response to the pollutant. Pollution can therefore alter interspecific competition dynamics between the malaria vector An. arabiensis and Cx. quinquefasciatus.
- 10 May 2023
- Published by Academy of Science of South Africa in African Entomology
- Vol. 31
Open AccessThe effect of pollution on the competitive dynamics of Anopheles arabiensis Patton, 1905 and Culex quinquefasciatus Say, 1823 (Diptera: Culicidae)
Culex quinquefasciatus Say, 1823 and Anopheles arabiensis Patton, 1905 (Diptera: Culicidae) are often found breeding in the same water sources and engage in interspecific competition. Although Cx. quinquefasciatus is known to proliferate in a range of polluted environments, the ability of An. arabiensis to proliferate in polluted water has only been reported relatively recently. The effects of pollution and insecticide resistance on this competitive interaction are unknown. This study examined the effect of pollution on the dynamics of the interspecific competition. Three laboratory strains were used in this study: an insecticide susceptible and an insecticide resistant An. arabiensis, and an insecticide resistant Cx. quinquefasciatus. Larval pollutant tolerances of each strain were assessed and compared by determining the lethal concentration at 50% mortality (LC50). The larvae from each strain were exposed to either inorganic fertiliser or copper nitrate, following which eclosion success was assessed. The results showed that the insecticide resistant strains had higher emergence rates when reared in polluted conditions without competition, with the Cx. quinquefasciatus strain showing the highest rate of eclosion. This species also had a higher tolerance for metal pollution than the An. arabiensis strains. The effects of pollutants on oviposition choice were examined. Pollution altered adult oviposition choice. The effect of larval metal exposure had variable effects on the activity of metabolic detoxification enzymes. An insecticide resistant phenotype had greater tolerance to pollutants and possibly developmental advantages based on a variable detoxification response to the pollutant. Pollution can therefore alter interspecific competition dynamics between the malaria vector An. arabiensis and Cx. quinquefasciatus.
- Open Access
- 5 October 2022
- Published by Wiley in Clinical and Translational Allergy
- Vol. 12 (10) , e12197
An interdisciplinary approach to characterize peanut‐allergic patients—First data from the FOOD@ consortium
Background: Peanut allergy is a frequent cause of food allergy and potentially life‐threatening. Within this interdisciplinary research approach, we aim to unravel the complex mechanisms of peanut allergy. As a first step were applied in an exploratory manner the analysis of peanut allergic versus non‐allergic controls.Methods: Biosamples were studied regarding DNA methylation signatures, gut microbiome, adaptive and innate immune cell populations, soluble signaling molecules and allergen‐reactive antibody specificities. We applied a scalable systems medicine computational workflow to the assembled data.Results: We identified combined cellular and soluble biomarker signatures that stratify donors into peanut‐allergic and non‐allergic with high specificity. DNA methylation profiling revealed various genes of interest and stool microbiota differences in bacteria abundances.Conclusion: By extending our findings to a larger set of patients (e.g., children vs. adults), we will establish predictors for food allergy and tolerance and translate these as for example, indicators for interventional studies.
- 5 October 2022
- Published by Wiley in Clinical and Translational Allergy
- Vol. 12 (10) , e12197
Open AccessAn interdisciplinary approach to characterize peanut‐allergic patients—First data from the FOOD@ consortium
Background: Peanut allergy is a frequent cause of food allergy and potentially life‐threatening. Within this interdisciplinary research approach, we aim to unravel the complex mechanisms of peanut allergy. As a first step were applied in an exploratory manner the analysis of peanut allergic versus non‐allergic controls.Methods: Biosamples were studied regarding DNA methylation signatures, gut microbiome, adaptive and innate immune cell populations, soluble signaling molecules and allergen‐reactive antibody specificities. We applied a scalable systems medicine computational workflow to the assembled data.Results: We identified combined cellular and soluble biomarker signatures that stratify donors into peanut‐allergic and non‐allergic with high specificity. DNA methylation profiling revealed various genes of interest and stool microbiota differences in bacteria abundances.Conclusion: By extending our findings to a larger set of patients (e.g., children vs. adults), we will establish predictors for food allergy and tolerance and translate these as for example, indicators for interventional studies.